Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia
about
Revisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behaviorNegative affective states and cognitive impairments in nicotine dependenceIncreased timing variability in schizophrenia and bipolar disorder.Alcohol use disorders contribute to hippocampal and subcortical shape differences in schizophrenia.Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjectsMedial temporal lobe structure and cognition in individuals with schizophrenia and in their non-psychotic siblingsPatterns of Tobacco Consumption among Indian Men with Schizophrenia Compared to Their Male SiblingsSmoking and schizophrenia in population cohorts of Swedish women and men: a prospective co-relative control study.Impact of Family History in Persons With Dual Diagnosis.Cannabis-related working memory deficits and associated subcortical morphological differences in healthy individuals and schizophrenia subjects.Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.Tobacco smoking is associated with psychotic experiences in the general population of South London.The link between schizophrenia and substance use disorder: A unifying hypothesis.Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction.Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophreniaIs it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured review.Cognitive functioning associated with stimulant use in patients with non-affective psychosis, their unaffected siblings and healthy controls.A functional neuregulin-1 gene variant and stressful life events: Effect on drug use in a longitudinal population-representative cohort study.Self-reported psychotic disorders among Individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
P2860
Q26801102-53C7B449-C789-454D-9C1E-01969C70DA65Q30371220-A08526B6-8500-4362-805B-630E7752BF3CQ33645390-DBD6610F-4E24-45BF-9FC2-D905195D06B0Q35175759-81DAABAD-613C-405E-ADE1-E57C0C0A4687Q35984216-7952A233-26AA-49BD-86C5-4D8F5E159D4CQ36024427-5D00F55E-22EC-4F46-AD7E-0312E175BA94Q36229920-18DFCAFD-83D2-4630-B7F7-5D53FD55761AQ36296644-D6DE6920-13B0-424E-96B8-8BAF222DC602Q36714184-2B15A2DC-3A6D-49DE-BDD7-46E86E5E9E02Q37598266-47C87026-1174-4465-A287-DB516C195CF2Q38124448-3D1FD8C3-C5F8-41BC-8029-E6863691D637Q38403649-B3174BA2-F18C-4CAD-B383-D2DBBA334819Q38729376-7721FFBE-52CA-4224-ACD4-BB72B90CDD36Q40321770-3B9D485D-A501-4555-9094-90A92D0D39C6Q42609446-6523D080-C2D8-43FA-8BAB-01962DB9B253Q45929001-F8DE7BE8-3997-44C9-8479-61ED9E797F1EQ46365588-7BAF3396-3604-4D03-A1DB-9A9DA2906AD2Q47945952-F10F6278-5AAC-45BC-8593-5F1375A5831CQ48651653-CF4C293A-C49B-43FE-8A89-F5C0786F902EQ50738681-6C91366C-1C20-4820-9428-F2FF07DC9382Q50993509-33612F3D-9DDD-40C2-813E-B727870E2718
P2860
Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated rates of substance us ...... individuals with schizophrenia
@en
Elevated rates of substance us ...... ndividuals with schizophrenia.
@nl
type
label
Elevated rates of substance us ...... individuals with schizophrenia
@en
Elevated rates of substance us ...... ndividuals with schizophrenia.
@nl
prefLabel
Elevated rates of substance us ...... individuals with schizophrenia
@en
Elevated rates of substance us ...... ndividuals with schizophrenia.
@nl
P2093
P2860
P921
P1476
Elevated rates of substance us ...... individuals with schizophrenia
@en
P2093
Daniel Mamah
John G Csernansky
Matthew J Smith
Timothy J Wolf
P2860
P304
P356
10.1016/J.SCHRES.2008.07.015
P407
P577
2008-09-05T00:00:00Z